Free shipping on all orders over $ 500

Danuglipron (PF-06882961)

Cat. No. M10311

All AbMole products are for research use only, cannot be used for human consumption.

Danuglipron (PF-06882961) Structure
Synonym:

PF06882961; Danuglipron

Size Price Availability Quantity
1mg USD 50  USD50 In stock
5mg USD 100  USD100 In stock
10mg USD 170  USD170 In stock
25mg USD 230  USD230 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Danuglipron (PF-06882961) is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R) agonist. PF-06882961 stimulates cAMP accumulation in CHO cells expressing both the human and monkey GLP-1Rs with comparable EC50 values. PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat.

Protocol (for reference only)
Cell Experiment
Cell lines HEK293 cells
Preparation method HEK293 cells stably expressing hGLP-1R fused to green fluorescent protein (GFP) (400,000 cells per well) are cultured onto 6 well plates for 24 hours and stimulated with PF-06882961 for 30 minutes. An agonist concentration of 1 μM shown to induce maximal internalization is chosen for these studies. In selected wells, cells are washed three times with PBS containing 0.1 % BSA and incubated at 37 °C for an additional 2 hours to assess reversibility of the endocytosis process. Cells are then fixed with 4% paraformaldehyde for 15 minutes at room temperature followed by three washes with PBS containing 0.1% BSA.
Concentrations 1 μM
Incubation time 30 minutes
Animal Experiment
Animal models male Wistar-Han rats / cynomolgus monkeys
Formulation -
Dosages 1 mg/kg iv; 5 mg/kg, 100 mg/kg PO
Administration iv, PO
Chemical Information
Molecular Weight 555.6
Formula C31H30FN5O4
CAS Number 2230198-02-2
Solubility (25°C) DMSO 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] David A. Griffith, et al. bioRxiv. A small-molecule oral agonist of the human glucagon-like peptide-1 receptor

[2] Hun Jee Choe, et al. Endocrinol Metab (Seoul). Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists

[3] Maria Mendez, et al. J Med Chem. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R)

Related GLP Receptor Products
V-0219 hydrochloride 

V-0219 hydrochloride is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R).

GLP-1 receptor agonist 14 

GLP-1 receptor agonist 14 is a potent agonist of glucagon-like peptide-1 (GLP-1).

NM-003

NM-003 is a GLP-2R agonist that can be used in studies related to inflammatory bowel disease.

NB-1002

NB-1002 is a GLP-2R agonist that can be used in studies related to short bowel syndrome.

MOD-15014

MOD-15014 is a GLP-2R modulator that can be used in studies related to short bowel syndrome.

  Catalog
Abmole Inhibitor Catalog




Keywords: Danuglipron (PF-06882961), PF06882961; Danuglipron supplier, GLP Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.